Related Experiment Video

Updated: Dec 13, 2025

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
07:16

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

4.2K

Characteristics and Outcomes of Hospitalized Young Adults with Mild Covid -19

Arvind Kumar Sharma1, Asrar Ahmed2, Vaseem Naheed Baig1

  • 1Department of Community Medicine, RUHS College of Medical Sciences, Rajasthan.

The Journal of the Association of Physicians of India
|August 3, 2020
PubMed

Insights

Mild COVID-19 cases in India, particularly younger patients, show excellent recovery. Most patients experienced mild symptoms, with rapid virus clearance and uncomplicated hospital stays, leading to all being discharged alive.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Public Health

Background:

  • COVID-19 has a severe course in hospitalized adults in high- and middle-income countries.
  • Clinical outcomes of mild COVID-19 in Indian hospitalized patients were assessed.

Purpose of the Study:

  • To evaluate the clinical outcomes of consecutively hospitalized patients with mild coronavirus disease 2019 (COVID-19) in India.

Main Methods:

  • A case registry of 501 patients admitted with suspected COVID-19 was established.
  • COVID-19 diagnosis was confirmed via reverse transcriptase polymerase chain reaction (RT-PCR).
  • Demographic, clinical, investigation, and outcome data were collected and analyzed using descriptive statistics.

Main Results:

  • COVID-19 was diagnosed in 234 patients (46.7%); 49% had a history of BCG vaccination compared to 10% of controls.
  • Mildly symptomatic or asymptomatic young patients (<40 years) showed rapid virus clearance (10.2±6.4 days).
  • One patient required oxygen support; all others had uncomplicated hospital courses and were discharged alive.

Conclusions:

  • Hospitalized, mildly symptomatic or asymptomatic young COVID-19 patients in India demonstrate an excellent prognosis.
  • The study highlights the generally favorable outcomes for mild COVID-19 cases in this demographic.
  • BCG vaccination history and age influenced virus clearance rates.
Abstract

More Related Videos

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.9K

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
678
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.2K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
862
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
643
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
601